Dosimetry for radiopharmaceutical therapy: From measurement to dose justification
Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…
Hunter Stephens, PhDJuly 7, 2026
Enhancing clinical trials with real-world evidence in pregnancy research
Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…
Alekhya Lavu, PhD, PharmDJune 26, 2026
Integrating Endogenous Ligand Competition into a Mechanistic Whole-Body PBPK Model of Therapeutic Monoclonal Antibodies
Discover how endogenous ligand competition was incorporated into a whole-body PBPK model to improve prediction…
CertaraJune 23, 2026
Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study
Learn how Certara's IO Simulator was used to predict efficacy, cytokine release syndrome risk, and…
CertaraJune 23, 2026
Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab
Discover how Quantitative Systems Pharmacology (QSP) was used to predict cytokine release syndrome risk and…
CertaraJune 23, 2026
Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development
Discover how a mechanistic quantitative systems pharmacology (QSP) model predicts mast cell inhibition and depletion…
CertaraJune 16, 2026
Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies
Explore how population PK modeling predicts absorbed dose and biologically effective dose for radioligand therapies.
CertaraJune 9, 2026
Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib
This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…
Dorottya Gui-BodnarMay 28, 2026
